Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Perforated peptic ulcer: how to improve outcome?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Time to onset of gastrointestinal bleeding in the SUP-ICU trial: a preplanned substudy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Heterogeneity of treatment effect of stress ulcer prophylaxis in ICU patients: A secondary analysis protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pantoprazole in ICU patients at risk for gastrointestinal bleeding-1-year mortality in the SUP-ICU trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Despite the introduction of histamine H2-receptor antagonists, proton-pump inhibitors and the discovery of Helicobacter pylori, both the incidence of emergency surgery for perforated peptic ulcer and the mortality rate for patients undergoing surgery for peptic ulcer perforation have increased. This increase has occurred despite improvements in perioperative treatment and monitoring. To improve the outcome of these patients, it is necessary to investigate the reasons behind this high mortality rate. In this review we evaluate the existing evidence in order to identify significant risk factors with an emphasis on risks that are preventable. A systematic review including randomized studies was carried out. There are a limited number of studies of patients with peptic ulcer perforation. Most of these studies are of low evident status. Only a few randomized, controlled trials have been published. The mortality rate and the extent of postoperative complications are fairly high but the reasons for this have not been thoroughly explained, even though a number of risk factors have been identified. Some of these risk factors can be explained by the septic state of the patient on admission. In order to improve the outcome of patients with peptic ulcer perforation, sepsis needs to be factored into the existing knowledge and treatment.
Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume44
Issue number1
Pages (from-to)15-22
Number of pages8
ISSN0036-5521
DOIs
Publication statusPublished - 1 Jan 2009

    Research areas

  • Anti-Inflammatory Agents, Non-Steroidal, Clinical Trials as Topic, Denmark, Duodenal Ulcer, Evidence-Based Medicine, Gastrectomy, Helicobacter Infections, Helicobacter pylori, Humans, Incidence, Meta-Analysis as Topic, Peptic Ulcer Perforation, Prevalence, Proton Pumps, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Smoking, Stomach Ulcer, Survival Rate

ID: 32797542